Incyte

INCY Scheduled selling only

CIK 0000879169 #251 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$2.80M

$0.00 on a plan · $2.80M straight out of an exercise

Sold at will

$0.00

0 of 2 sales

Net

−$2.80M

$0.00 against sales at will

By person

27 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

CAGNONI PABLO J

President, Global Head of R&D

—

$2.80M (2) scheduled

−$2.80M

183,200

0.0904%

$22.07M

−18.5%

BAKER BROS. ADVISORS LP entity

Director

—

—

—

28,205,760

13.92%

$3.40B

+0.2%

Hoppenot Herve

Director

—

—

—

326,803

0.1612%

$39.38M

−34.2%

Meury William

Chief Executive Officer

—

—

—

183,129

0.0903%

$22.07M

—

Stamoulis Christiana

EVP & Chief Financial Officer

—

—

—

125,759

0.0620%

$15.15M

+32.1%

SWAIN PAULA J

EVP, Human Resources

—

—

—

106,482

0.0525%

$12.83M

+23.7%

Issa Mohamed Khairie

EVP, Head of U.S. Commercial

—

—

—

71,797

0.0354%

$8.65M

—

Mayes Patrick A

EVP & Chief Scientific Officer

—

—

—

61,441

0.0303%

$7.40M

−8.8%

Iyengar Vijay K

EVP, GMAPPS

—

—

—

40,540

0.0200%

$4.88M

+9.5%

Heeson Lee

EVP, Head of Incyte Intl

—

—

—

38,041

0.0188%

$4.58M

—

Flannelly Barry P

EVP & General Manager US

—

—

—

35,149

0.0173%

$4.24M

−39.4%

Morrissey Michael James

EVP, Head of Tech. Operations

—

—

—

34,065

0.0168%

$4.10M

−52.9%

Stein Steven H

CMO & Head of Late-Stage Dev.

—

—

—

30,916

0.0153%

$3.73M

−67.5%

Denton Sheila A.

EVP & General Counsel

—

—

—

26,569

0.0131%

$3.20M

−19.8%

Upadhyay Suketu

EVP & Chief Financial Officer

—

—

—

26,343

0.0130%

$3.17M

—

Clancy Paul J

Director

—

—

—

25,635

0.0126%

$3.09M

+34.8%

BIENAIME JEAN JACQUES

Director

—

—

—

24,424

0.0120%

$2.94M

+33.3%

HARRIGAN EDMUND

Director

—

—

—

23,019

0.0114%

$2.77M

+40.8%

Tray Thomas

Principal Accounting Officer

—

—

—

21,699

0.0107%

$2.61M

−13.7%

FOUSE JACQUALYN A

Director

—

—

—

20,968

0.0103%

$2.53M

+24.8%

Hoffman Richard A.

EVP & General Counsel

—

—

—

16,861

0.0083%

$2.03M

—

Gardner David H

EVP, Chief Strategy Officer

—

—

—

16,824

0.0083%

$2.03M

—

High Katherine A

Director

—

—

—

14,983

0.0074%

$1.81M

+38.4%

Trotta Matteo

EVP, GM, Dermatology US

—

—

—

14,882

0.0073%

$1.79M

+36.8%

BRAWLEY OTIS W

Director

—

—

—

12,894

0.0064%

$1.55M

+47.6%

Basi Ramitpal K

EVP, Human Resources

—

—

—

10,993

0.0054%

$1.32M

—

Schaffert Susanne

Director

—

—

—

7,389

0.0036%

$890.30K

+29.2%

Individual transactions

2

Insider

Date

Role

Action

Shares

Price

Amount

CAGNONI PABLO J

15 Sep 2026

President, Global Head of R&D

Sold after exercise

13,985

$120.49

$1.69M

CAGNONI PABLO J

15 Sep 2026

President, Global Head of R&D

Sold after exercise

9,233

$120.50

$1.11M

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 2

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 23,722

History held since 26 Sep 2016